Clinical Trial: "Eye Protection After Mydriatic Use for ROP Screening: Impact on Vitals Signs and Pain Scores"

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: "Eye Protection After Mydriatic Use for ROP Screening: Impact on Vitals Signs and Pain Scores"

Brief Summary: Pupillary dilation induced by mydriatic agents during Retinopathy of Prematurity exams can persist for hours. Despite regular use of eye protection for mydriatic-induced light sensitivity for infants, children and adults, eye protection after mydriasis has not been addressed in neonates. This study examines the use of eye patches to protect the dilated pupil from light exposure and their impact on vital signs and pain scores. prevents tachycardia, tachypnea and discomfort in neonates after ROP screening.